APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vaccine Adjuvants

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

Selected research

Market Analysis & Forecast

Global Vaccine Adjuvants Market Analysis and Forecast 2026-2032

25 December 2025192 pages

Choose your research edition.

Industry ResearchVaccine Adjuvants Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaccine Adjuvants Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Vaccine Adjuvants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaccine Adjuvants Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Vaccine Adjuvants Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

The top 5 global manufacturers of vaccine adjuvants are GSK, CSL Limited, Croda, SEPPIC, Novavax, which have a combined market share of about 55 percent. North America is the largest market, with a share about 38%, followed by Europe and Asia Pacific with the share about 27% and 22%.

This report presents an overview of global market for Vaccine Adjuvants, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Vaccine Adjuvants, also provides the sales of main regions and countries. Of the upcoming market potential for Vaccine Adjuvants, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Vaccine Adjuvants sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Vaccine Adjuvants market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Vaccine Adjuvants sales, projected growth trends, production technology, application and end-user industry.

Vaccine Adjuvants Segment by Company

GSK

CSL Limited

Croda

SEPPIC

Novavax

SPI Pharma

Phibro

SDA BIO

Invivogen

Tj Kaiwei

OZ Biosciences

Brenntag Biosector

MVP Laboratories

Zhuoyue

Aphios

Vaccine Adjuvants Segment by Type

Aluminum Adjuvant

Emulsions Adjuvant

Others

Vaccine Adjuvants Segment by Application

Human Vaccine

Veterinary Vaccine

Vaccine Adjuvants Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine Adjuvants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaccine Adjuvants and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine Adjuvants.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Vaccine Adjuvants in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Vaccine Adjuvants manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vaccine Adjuvants sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Vaccine Adjuvants Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Aluminum Adjuvant Major Manufacturers Table 3. Emulsions Adjuvant Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Vaccine Adjuvants Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Human Vaccine Major Manufacturers Table 7. Veterinary Vaccine Major Manufacturers Table 8. Vaccine Adjuvants Industry Trends Table 9. Vaccine Adjuvants Industry Drivers Table 10. Vaccine Adjuvants Industry Opportunities and Challenges Table 11. Vaccine Adjuvants Industry Restraints Table 12. Global Vaccine Adjuvants Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Vaccine Adjuvants Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Vaccine Adjuvants Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Vaccine Adjuvants Revenue Market Share by Region (2021-2026) Table 16. Global Vaccine Adjuvants Revenue Market Share by Region (2027-2032) Table 17. Global Vaccine Adjuvants Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (MT) Table 18. Global Vaccine Adjuvants Sales by Region (2021-2026) & (MT) Table 19. Global Vaccine Adjuvants Sales by Region (2027-2032) & (MT) Table 20. Global Vaccine Adjuvants Sales Market Share by Region (2021-2026) Table 21. Global Vaccine Adjuvants Sales Market Share by Region (2027-2032) Table 22. Global Vaccine Adjuvants Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Vaccine Adjuvants Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Vaccine Adjuvants Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Vaccine Adjuvants Sales Market Share by Manufacturers (2021-2026) Table 26. Global Vaccine Adjuvants Sales Price (USD/Kg) of Manufacturers (2021-2026) Table 27. Global Vaccine Adjuvants Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Vaccine Adjuvants Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Vaccine Adjuvants Manufacturers, Product Type & Application Table 30. Global Vaccine Adjuvants Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Vaccine Adjuvants by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Vaccine Adjuvants Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Vaccine Adjuvants Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Vaccine Adjuvants Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Vaccine Adjuvants Revenue Market Share by Type (2021-2026) Table 37. Global Vaccine Adjuvants Revenue Market Share by Type (2027-2032) Table 38. Global Vaccine Adjuvants Sales by Type 2021 VS 2025 VS 2032 (MT) Table 39. Global Vaccine Adjuvants Sales by Type (2021-2026) & (MT) Table 40. Global Vaccine Adjuvants Sales by Type (2027-2032) & (MT) Table 41. Global Vaccine Adjuvants Sales Market Share by Type (2021-2026) Table 42. Global Vaccine Adjuvants Sales Market Share by Type (2027-2032) Table 43. Global Vaccine Adjuvants Price by Type (2021-2026) & (USD/Kg) Table 44. Global Vaccine Adjuvants Price by Type (2027-2032) & (USD/Kg) Table 45. Global Vaccine Adjuvants Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Vaccine Adjuvants Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Vaccine Adjuvants Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Vaccine Adjuvants Revenue Market Share by Application (2021-2026) Table 49. Global Vaccine Adjuvants Revenue Market Share by Application (2027-2032) Table 50. Global Vaccine Adjuvants Sales by Application 2021 VS 2025 VS 2032 (MT) Table 51. Global Vaccine Adjuvants Sales by Application (2021-2026) & (MT) Table 52. Global Vaccine Adjuvants Sales by Application (2027-2032) & (MT) Table 53. Global Vaccine Adjuvants Sales Market Share by Application (2021-2026) Table 54. Global Vaccine Adjuvants Sales Market Share by Application (2027-2032) Table 55. Global Vaccine Adjuvants Price by Application (2021-2026) & (USD/Kg) Table 56. Global Vaccine Adjuvants Price by Application (2027-2032) & (USD/Kg) Table 57. GSK Company Information Table 58. GSK Business Overview Table 59. GSK Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 60. GSK Vaccine Adjuvants Product Portfolio Table 61. GSK Recent Development Table 62. CSL Limited Company Information Table 63. CSL Limited Business Overview Table 64. CSL Limited Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 65. CSL Limited Vaccine Adjuvants Product Portfolio Table 66. CSL Limited Recent Development Table 67. Croda Company Information Table 68. Croda Business Overview Table 69. Croda Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 70. Croda Vaccine Adjuvants Product Portfolio Table 71. Croda Recent Development Table 72. SEPPIC Company Information Table 73. SEPPIC Business Overview Table 74. SEPPIC Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 75. SEPPIC Vaccine Adjuvants Product Portfolio Table 76. SEPPIC Recent Development Table 77. Novavax Company Information Table 78. Novavax Business Overview Table 79. Novavax Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 80. Novavax Vaccine Adjuvants Product Portfolio Table 81. Novavax Recent Development Table 82. SPI Pharma Company Information Table 83. SPI Pharma Business Overview Table 84. SPI Pharma Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 85. SPI Pharma Vaccine Adjuvants Product Portfolio Table 86. SPI Pharma Recent Development Table 87. Phibro Company Information Table 88. Phibro Business Overview Table 89. Phibro Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 90. Phibro Vaccine Adjuvants Product Portfolio Table 91. Phibro Recent Development Table 92. SDA BIO Company Information Table 93. SDA BIO Business Overview Table 94. SDA BIO Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 95. SDA BIO Vaccine Adjuvants Product Portfolio Table 96. SDA BIO Recent Development Table 97. Invivogen Company Information Table 98. Invivogen Business Overview Table 99. Invivogen Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 100. Invivogen Vaccine Adjuvants Product Portfolio Table 101. Invivogen Recent Development Table 102. Tj Kaiwei Company Information Table 103. Tj Kaiwei Business Overview Table 104. Tj Kaiwei Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 105. Tj Kaiwei Vaccine Adjuvants Product Portfolio Table 106. Tj Kaiwei Recent Development Table 107. OZ Biosciences Company Information Table 108. OZ Biosciences Business Overview Table 109. OZ Biosciences Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 110. OZ Biosciences Vaccine Adjuvants Product Portfolio Table 111. OZ Biosciences Recent Development Table 112. Brenntag Biosector Company Information Table 113. Brenntag Biosector Business Overview Table 114. Brenntag Biosector Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 115. Brenntag Biosector Vaccine Adjuvants Product Portfolio Table 116. Brenntag Biosector Recent Development Table 117. MVP Laboratories Company Information Table 118. MVP Laboratories Business Overview Table 119. MVP Laboratories Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 120. MVP Laboratories Vaccine Adjuvants Product Portfolio Table 121. MVP Laboratories Recent Development Table 122. Zhuoyue Company Information Table 123. Zhuoyue Business Overview Table 124. Zhuoyue Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 125. Zhuoyue Vaccine Adjuvants Product Portfolio Table 126. Zhuoyue Recent Development Table 127. Aphios Company Information Table 128. Aphios Business Overview Table 129. Aphios Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 130. Aphios Vaccine Adjuvants Product Portfolio Table 131. Aphios Recent Development Table 132. North America Vaccine Adjuvants Revenue by Type (2021-2026) & (US$ Million) Table 133. North America Vaccine Adjuvants Revenue by Type (2027-2032) & (US$ Million) Table 134. North America Vaccine Adjuvants Sales by Type (2021-2026) & (MT) Table 135. North America Vaccine Adjuvants Sales by Type (2027-2032) & (MT) Table 136. North America Vaccine Adjuvants Sales Price by Type (2021-2026) & (USD/Kg) Table 137. North America Vaccine Adjuvants Sales Price by Type (2027-2032) & (USD/Kg) Table 138. North America Vaccine Adjuvants Revenue by Application (2021-2026) & (US$ Million) Table 139. North America Vaccine Adjuvants Revenue by Application (2027-2032) & (US$ Million) Table 140. North America Vaccine Adjuvants Sales by Application (2021-2026) & (MT) Table 141. North America Vaccine Adjuvants Sales by Application (2027-2032) & (MT) Table 142. North America Vaccine Adjuvants Sales Price by Application (2021-2026) & (USD/Kg) Table 143. North America Vaccine Adjuvants Sales Price by Application (2027-2032) & (USD/Kg) Table 144. North America Vaccine Adjuvants Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. North America Vaccine Adjuvants Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. North America Vaccine Adjuvants Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. North America Vaccine Adjuvants Sales by Country (2021 VS 2025 VS 2032) & (MT) Table 148. North America Vaccine Adjuvants Sales by Country (2021-2026) & (MT) Table 149. North America Vaccine Adjuvants Sales by Country (2027-2032) & (MT) Table 150. North America Vaccine Adjuvants Sales Price by Country (2021-2026) & (USD/Kg) Table 151. North America Vaccine Adjuvants Sales Price by Country (2027-2032) & (USD/Kg) Table 152. United States Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 153. Canada Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 154. Mexico Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 155. Europe Vaccine Adjuvants Revenue by Type (2021-2026) & (US$ Million) Table 156. Europe Vaccine Adjuvants Revenue by Type (2027-2032) & (US$ Million) Table 157. Europe Vaccine Adjuvants Sales by Type (2021-2026) & (MT) Table 158. Europe Vaccine Adjuvants Sales by Type (2027-2032) & (MT) Table 159. Europe Vaccine Adjuvants Sales Price by Type (2021-2026) & (USD/Kg) Table 160. Europe Vaccine Adjuvants Sales Price by Type (2027-2032) & (USD/Kg) Table 161. Europe Vaccine Adjuvants Revenue by Application (2021-2026) & (US$ Million) Table 162. Europe Vaccine Adjuvants Revenue by Application (2027-2032) & (US$ Million) Table 163. Europe Vaccine Adjuvants Sales by Application (2021-2026) & (MT) Table 164. Europe Vaccine Adjuvants Sales by Application (2027-2032) & (MT) Table 165. Europe Vaccine Adjuvants Sales Price by Application (2021-2026) & (USD/Kg) Table 166. Europe Vaccine Adjuvants Sales Price by Application (2027-2032) & (USD/Kg) Table 167. Europe Vaccine Adjuvants Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. Europe Vaccine Adjuvants Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 169. Europe Vaccine Adjuvants Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 170. Europe Vaccine Adjuvants Sales by Country (2021 VS 2025 VS 2032) & (MT) Table 171. Europe Vaccine Adjuvants Sales by Country (2021-2026) & (MT) Table 172. Europe Vaccine Adjuvants Sales by Country (2027-2032) & (MT) Table 173. Europe Vaccine Adjuvants Sales Price by Country (2021-2026) & (USD/Kg) Table 174. Europe Vaccine Adjuvants Sales Price by Country (2027-2032) & (USD/Kg) Table 175. Germany Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 176. France Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 177. U.K. Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 178. Italy Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 179. Russia Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 180. Spain Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 181. Netherlands Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 182. Switzerland Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 183. Sweden Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 184. Poland Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 185. China Vaccine Adjuvants Revenue by Type (2021-2026) & (US$ Million) Table 186. China Vaccine Adjuvants Revenue by Type (2027-2032) & (US$ Million) Table 187. China Vaccine Adjuvants Sales by Type (2021-2026) & (MT) Table 188. China Vaccine Adjuvants Sales by Type (2027-2032) & (MT) Table 189. China Vaccine Adjuvants Sales Price by Type (2021-2026) & (USD/Kg) Table 190. China Vaccine Adjuvants Sales Price by Type (2027-2032) & (USD/Kg) Table 191. China Vaccine Adjuvants Revenue by Application (2021-2026) & (US$ Million) Table 192. China Vaccine Adjuvants Revenue by Application (2027-2032) & (US$ Million) Table 193. China Vaccine Adjuvants Sales by Application (2021-2026) & (MT) Table 194. China Vaccine Adjuvants Sales by Application (2027-2032) & (MT) Table 195. China Vaccine Adjuvants Sales Price by Application (2021-2026) & (USD/Kg) Table 196. China Vaccine Adjuvants Sales Price by Application (2027-2032) & (USD/Kg) Table 197. Asia Vaccine Adjuvants Revenue by Type (2021-2026) & (US$ Million) Table 198. Asia Vaccine Adjuvants Revenue by Type (2027-2032) & (US$ Million) Table 199. Asia Vaccine Adjuvants Sales by Type (2021-2026) & (MT) Table 200. Asia Vaccine Adjuvants Sales by Type (2027-2032) & (MT) Table 201. Asia Vaccine Adjuvants Sales Price by Type (2021-2026) & (USD/Kg) Table 202. Asia Vaccine Adjuvants Sales Price by Type (2027-2032) & (USD/Kg) Table 203. Asia Vaccine Adjuvants Revenue by Application (2021-2026) & (US$ Million) Table 204. Asia Vaccine Adjuvants Revenue by Application (2027-2032) & (US$ Million) Table 205. Asia Vaccine Adjuvants Sales by Application (2021-2026) & (MT) Table 206. Asia Vaccine Adjuvants Sales by Application (2027-2032) & (MT) Table 207. Asia Vaccine Adjuvants Sales Price by Application (2021-2026) & (USD/Kg) Table 208. Asia Vaccine Adjuvants Sales Price by Application (2027-2032) & (USD/Kg) Table 209. Asia Vaccine Adjuvants Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 210. Asia Vaccine Adjuvants Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 211. Asia Vaccine Adjuvants Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 212. Asia Vaccine Adjuvants Sales by Country (2021 VS 2025 VS 2032) & (MT) Table 213. Asia Vaccine Adjuvants Sales by Country (2021-2026) & (MT) Table 214. Asia Vaccine Adjuvants Sales by Country (2027-2032) & (MT) Table 215. Asia Vaccine Adjuvants Sales Price by Country (2021-2026) & (USD/Kg) Table 216. Asia Vaccine Adjuvants Sales Price by Country (2027-2032) & (USD/Kg) Table 217. Japan Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 218. South Korea Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 219. India Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 220. Australia Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 221. Taiwan Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 222. Southeast Asia Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 223. SAMEA Vaccine Adjuvants Revenue by Type (2021-2026) & (US$ Million) Table 224. SAMEA Vaccine Adjuvants Revenue by Type (2027-2032) & (US$ Million) Table 225. SAMEA Vaccine Adjuvants Sales by Type (2021-2026) & (MT) Table 226. SAMEA Vaccine Adjuvants Sales by Type (2027-2032) & (MT) Table 227. SAMEA Vaccine Adjuvants Sales Price by Type (2021-2026) & (USD/Kg) Table 228. SAMEA Vaccine Adjuvants Sales Price by Type (2027-2032) & (USD/Kg) Table 229. SAMEA Vaccine Adjuvants Revenue by Application (2021-2026) & (US$ Million) Table 230. SAMEA Vaccine Adjuvants Revenue by Application (2027-2032) & (US$ Million) Table 231. SAMEA Vaccine Adjuvants Sales by Application (2021-2026) & (MT) Table 232. SAMEA Vaccine Adjuvants Sales by Application (2027-2032) & (MT) Table 233. SAMEA Vaccine Adjuvants Sales Price by Application (2021-2026) & (USD/Kg) Table 234. SAMEA Vaccine Adjuvants Sales Price by Application (2027-2032) & (USD/Kg) Table 235. SAMEA Vaccine Adjuvants Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 236. SAMEA Vaccine Adjuvants Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 237. SAMEA Vaccine Adjuvants Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 238. SAMEA Vaccine Adjuvants Sales by Country (2021 VS 2025 VS 2032) & (MT) Table 239. SAMEA Vaccine Adjuvants Sales by Country (2021-2026) & (MT) Table 240. SAMEA Vaccine Adjuvants Sales by Country (2027-2032) & (MT) Table 241. SAMEA Vaccine Adjuvants Sales Price by Country (2021-2026) & (USD/Kg) Table 242. SAMEA Vaccine Adjuvants Sales Price by Country (2027-2032) & (USD/Kg) Table 243. Brazil Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 244. Argentina Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 245. Chile Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 246. Colombia Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 247. Peru Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 248. Saudi Arabia Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 249. Israel Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 250. UAE Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 251. Turkey Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 252. Iran Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 253. Egypt Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Table 254. Key Raw Materials Table 255. Raw Materials Key Suppliers Table 256. Vaccine Adjuvants Distributors List Table 257. Vaccine Adjuvants Customers List Table 258. Research Programs/Design for This Report Table 259. Authors List of This Report Table 260. Secondary Sources Table 261. Primary Sources List of Figures Figure 1. Vaccine Adjuvants Image Figure 2. Global Vaccine Adjuvants Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vaccine Adjuvants Market Size Share 2021 VS 2025 VS 2032 Figure 4. Aluminum Adjuvant Image Figure 5. Emulsions Adjuvant Image Figure 6. Others Image Figure 7. Global Vaccine Adjuvants Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Vaccine Adjuvants Market Size Share 2021 VS 2025 VS 2032 Figure 9. Human Vaccine Image Figure 10. Veterinary Vaccine Image Figure 11. Global Vaccine Adjuvants Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Vaccine Adjuvants Revenue (2021-2032) & (US$ Million) Figure 13. Global Vaccine Adjuvants Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Vaccine Adjuvants Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Vaccine Adjuvants Revenue Market Share by Region (2021-2032) Figure 16. Global Vaccine Adjuvants Sales (2021-2032) & (MT) Figure 17. Global Vaccine Adjuvants Sales by Region: 2021 VS 2025 VS 2032 (MT) Figure 18. Global Vaccine Adjuvants Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Vaccine Adjuvants Sales YoY (2021-2032) & (MT) Figure 20. Europe Vaccine Adjuvants Sales YoY (2021-2032) & (MT) Figure 21. China Vaccine Adjuvants Sales YoY (2021-2032) & (MT) Figure 22. Asia (Excluding China) Vaccine Adjuvants Sales YoY (2021-2032) & (MT) Figure 23. South America, Middle East and Africa Vaccine Adjuvants Sales YoY (2021-2032) & (MT) Figure 24. Global Vaccine Adjuvants Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Vaccine Adjuvants Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Vaccine Adjuvants Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Vaccine Adjuvants Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Vaccine Adjuvants Revenue Market Share by Type (2021-2032) Figure 30. Global Vaccine Adjuvants Sales by Type (2021 VS 2025 VS 2032) & (MT) Figure 31. Global Vaccine Adjuvants Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Vaccine Adjuvants Sales Market Share by Type (2021-2032) Figure 33. Global Vaccine Adjuvants Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Vaccine Adjuvants Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Vaccine Adjuvants Revenue Market Share by Application (2021-2032) Figure 36. Global Vaccine Adjuvants Sales by Application (2021 VS 2025 VS 2032) & (MT) Figure 37. Global Vaccine Adjuvants Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Vaccine Adjuvants Sales Market Share by Application (2021-2032) Figure 39. North America Vaccine Adjuvants Revenue Share by Type (2021-2032) Figure 40. North America Vaccine Adjuvants Sales Share by Type (2021-2032) Figure 41. North America Vaccine Adjuvants Revenue Share by Application (2021-2032) Figure 42. North America Vaccine Adjuvants Sales Share by Application (2021-2032) Figure 43. North America Vaccine Adjuvants Revenue Share by Country (2021-2032) Figure 44. North America Vaccine Adjuvants Sales Share by Country (2021-2032) Figure 45. Europe Vaccine Adjuvants Revenue Share by Type (2021-2032) Figure 46. Europe Vaccine Adjuvants Sales Share by Type (2021-2032) Figure 47. Europe Vaccine Adjuvants Revenue Share by Application (2021-2032) Figure 48. Europe Vaccine Adjuvants Sales Share by Application (2021-2032) Figure 49. Europe Vaccine Adjuvants Revenue Share by Country (2021-2032) Figure 50. Europe Vaccine Adjuvants Sales Share by Country (2021-2032) Figure 51. China Vaccine Adjuvants Revenue Share by Type (2021-2032) Figure 52. China Vaccine Adjuvants Sales Share by Type (2021-2032) Figure 53. China Vaccine Adjuvants Revenue Share by Application (2021-2032) Figure 54. China Vaccine Adjuvants Sales Share by Application (2021-2032) Figure 55. Asia Vaccine Adjuvants Revenue Share by Type (2021-2032) Figure 56. Asia Vaccine Adjuvants Sales Share by Type (2021-2032) Figure 57. Asia Vaccine Adjuvants Revenue Share by Application (2021-2032) Figure 58. Asia Vaccine Adjuvants Sales Share by Application (2021-2032) Figure 59. Asia Vaccine Adjuvants Revenue Share by Country (2021-2032) Figure 60. Asia Vaccine Adjuvants Sales Share by Country (2021-2032) Figure 61. SAMEA Vaccine Adjuvants Revenue Share by Type (2021-2032) Figure 62. SAMEA Vaccine Adjuvants Sales Share by Type (2021-2032) Figure 63. SAMEA Vaccine Adjuvants Revenue Share by Application (2021-2032) Figure 64. SAMEA Vaccine Adjuvants Sales Share by Application (2021-2032) Figure 65. SAMEA Vaccine Adjuvants Revenue Share by Country (2021-2032) Figure 66. SAMEA Vaccine Adjuvants Sales Share by Country (2021-2032) Figure 67. Vaccine Adjuvants Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Vaccine Adjuvants Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Aluminum Adjuvant
  • Emulsions Adjuvant
  • Others
Applications
  • Human Vaccine
  • Veterinary Vaccine
Companies covered
  • GSK
  • CSL Limited
  • Croda
  • SEPPIC
  • Novavax
  • SPI Pharma
  • Phibro
  • SDA BIO
  • Invivogen
  • Tj Kaiwei
  • OZ Biosciences
  • Brenntag Biosector
  • MVP Laboratories
  • Zhuoyue
  • Aphios

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Vaccine Adjuvants Market by Type
  3. 1.2.1 Global Vaccine Adjuvants Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Aluminum Adjuvant
  5. 1.2.3 Emulsions Adjuvant
  6. 1.2.4 Others
  7. 1.3 Vaccine Adjuvants Market by Application
  8. 1.3.1 Global Vaccine Adjuvants Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Human Vaccine
  10. 1.3.3 Veterinary Vaccine
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Vaccine Adjuvants Market Dynamics
  1. 2.1 Vaccine Adjuvants Industry Trends
  2. 2.2 Vaccine Adjuvants Industry Drivers
  3. 2.3 Vaccine Adjuvants Industry Opportunities and Challenges
  4. 2.4 Vaccine Adjuvants Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Vaccine Adjuvants Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Vaccine Adjuvants Revenue by Region
  3. 3.2.1 Global Vaccine Adjuvants Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Vaccine Adjuvants Revenue by Region (2021-2026)
  5. 3.2.3 Global Vaccine Adjuvants Revenue by Region (2027-2032)
  6. 3.2.4 Global Vaccine Adjuvants Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Vaccine Adjuvants Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Vaccine Adjuvants Sales by Region
  9. 3.4.1 Global Vaccine Adjuvants Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Vaccine Adjuvants Sales by Region (2021-2026)
  11. 3.4.3 Global Vaccine Adjuvants Sales by Region (2027-2032)
  12. 3.4.4 Global Vaccine Adjuvants Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Vaccine Adjuvants Revenue by Manufacturers
  2. 4.1.1 Global Vaccine Adjuvants Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Vaccine Adjuvants Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Vaccine Adjuvants Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Vaccine Adjuvants Sales by Manufacturers
  6. 4.2.1 Global Vaccine Adjuvants Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Vaccine Adjuvants Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Vaccine Adjuvants Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Vaccine Adjuvants Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Vaccine Adjuvants Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Vaccine Adjuvants Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Vaccine Adjuvants Manufacturers, Product Type & Application
  13. 4.7 Global Vaccine Adjuvants Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Vaccine Adjuvants Market CR5 and HHI
  16. 4.8.2 2025 Vaccine Adjuvants Tier 1, Tier 2, and Tier 3
5 Vaccine Adjuvants Market by Type
  1. 5.1 Global Vaccine Adjuvants Revenue by Type
  2. 5.1.1 Global Vaccine Adjuvants Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Vaccine Adjuvants Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Vaccine Adjuvants Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Vaccine Adjuvants Sales by Type
  6. 5.2.1 Global Vaccine Adjuvants Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Vaccine Adjuvants Sales by Type (2021-2032) & (MT)
  8. 5.2.3 Global Vaccine Adjuvants Sales Market Share by Type (2021-2032)
  9. 5.3 Global Vaccine Adjuvants Price by Type
6 Vaccine Adjuvants Market by Application
  1. 6.1 Global Vaccine Adjuvants Revenue by Application
  2. 6.1.1 Global Vaccine Adjuvants Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Vaccine Adjuvants Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Vaccine Adjuvants Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Vaccine Adjuvants Sales by Application
  6. 6.2.1 Global Vaccine Adjuvants Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Vaccine Adjuvants Sales by Application (2021-2032) & (MT)
  8. 6.2.3 Global Vaccine Adjuvants Sales Market Share by Application (2021-2032)
  9. 6.3 Global Vaccine Adjuvants Price by Application
7 Company Profiles
  1. 7.1 GSK
  2. 7.1.1 GSK Company Information
  3. 7.1.2 GSK Business Overview
  4. 7.1.3 GSK Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 GSK Vaccine Adjuvants Product Portfolio
  6. 7.1.5 GSK Recent Developments
  7. 7.2 CSL Limited
  8. 7.2.1 CSL Limited Company Information
  9. 7.2.2 CSL Limited Business Overview
  10. 7.2.3 CSL Limited Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 CSL Limited Vaccine Adjuvants Product Portfolio
  12. 7.2.5 CSL Limited Recent Developments
  13. 7.3 Croda
  14. 7.3.1 Croda Company Information
  15. 7.3.2 Croda Business Overview
  16. 7.3.3 Croda Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Croda Vaccine Adjuvants Product Portfolio
  18. 7.3.5 Croda Recent Developments
  19. 7.4 SEPPIC
  20. 7.4.1 SEPPIC Company Information
  21. 7.4.2 SEPPIC Business Overview
  22. 7.4.3 SEPPIC Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 SEPPIC Vaccine Adjuvants Product Portfolio
  24. 7.4.5 SEPPIC Recent Developments
  25. 7.5 Novavax
  26. 7.5.1 Novavax Company Information
  27. 7.5.2 Novavax Business Overview
  28. 7.5.3 Novavax Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Novavax Vaccine Adjuvants Product Portfolio
  30. 7.5.5 Novavax Recent Developments
  31. 7.6 SPI Pharma
  32. 7.6.1 SPI Pharma Company Information
  33. 7.6.2 SPI Pharma Business Overview
  34. 7.6.3 SPI Pharma Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 SPI Pharma Vaccine Adjuvants Product Portfolio
  36. 7.6.5 SPI Pharma Recent Developments
  37. 7.7 Phibro
  38. 7.7.1 Phibro Company Information
  39. 7.7.2 Phibro Business Overview
  40. 7.7.3 Phibro Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Phibro Vaccine Adjuvants Product Portfolio
  42. 7.7.5 Phibro Recent Developments
  43. 7.8 SDA BIO
  44. 7.8.1 SDA BIO Company Information
  45. 7.8.2 SDA BIO Business Overview
  46. 7.8.3 SDA BIO Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 SDA BIO Vaccine Adjuvants Product Portfolio
  48. 7.8.5 SDA BIO Recent Developments
  49. 7.9 Invivogen
  50. 7.9.1 Invivogen Company Information
  51. 7.9.2 Invivogen Business Overview
  52. 7.9.3 Invivogen Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Invivogen Vaccine Adjuvants Product Portfolio
  54. 7.9.5 Invivogen Recent Developments
  55. 7.10 Tj Kaiwei
  56. 7.10.1 Tj Kaiwei Company Information
  57. 7.10.2 Tj Kaiwei Business Overview
  58. 7.10.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Tj Kaiwei Vaccine Adjuvants Product Portfolio
  60. 7.10.5 Tj Kaiwei Recent Developments
  61. 7.11 OZ Biosciences
  62. 7.11.1 OZ Biosciences Company Information
  63. 7.11.2 OZ Biosciences Business Overview
  64. 7.11.3 OZ Biosciences Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 OZ Biosciences Vaccine Adjuvants Product Portfolio
  66. 7.11.5 OZ Biosciences Recent Developments
  67. 7.12 Brenntag Biosector
  68. 7.12.1 Brenntag Biosector Company Information
  69. 7.12.2 Brenntag Biosector Business Overview
  70. 7.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Brenntag Biosector Vaccine Adjuvants Product Portfolio
  72. 7.12.5 Brenntag Biosector Recent Developments
  73. 7.13 MVP Laboratories
  74. 7.13.1 MVP Laboratories Company Information
  75. 7.13.2 MVP Laboratories Business Overview
  76. 7.13.3 MVP Laboratories Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 MVP Laboratories Vaccine Adjuvants Product Portfolio
  78. 7.13.5 MVP Laboratories Recent Developments
  79. 7.14 Zhuoyue
  80. 7.14.1 Zhuoyue Company Information
  81. 7.14.2 Zhuoyue Business Overview
  82. 7.14.3 Zhuoyue Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Zhuoyue Vaccine Adjuvants Product Portfolio
  84. 7.14.5 Zhuoyue Recent Developments
  85. 7.15 Aphios
  86. 7.15.1 Aphios Company Information
  87. 7.15.2 Aphios Business Overview
  88. 7.15.3 Aphios Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Aphios Vaccine Adjuvants Product Portfolio
  90. 7.15.5 Aphios Recent Developments
8 North America
  1. 8.1 North America Vaccine Adjuvants Market Size by Type
  2. 8.1.1 North America Vaccine Adjuvants Revenue by Type (2021-2032)
  3. 8.1.2 North America Vaccine Adjuvants Sales by Type (2021-2032)
  4. 8.1.3 North America Vaccine Adjuvants Price by Type (2021-2032)
  5. 8.2 North America Vaccine Adjuvants Market Size by Application
  6. 8.2.1 North America Vaccine Adjuvants Revenue by Application (2021-2032)
  7. 8.2.2 North America Vaccine Adjuvants Sales by Application (2021-2032)
  8. 8.2.3 North America Vaccine Adjuvants Price by Application (2021-2032)
  9. 8.3 North America Vaccine Adjuvants Market Size by Country
  10. 8.3.1 North America Vaccine Adjuvants Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Vaccine Adjuvants Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Vaccine Adjuvants Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Vaccine Adjuvants Market Size by Type
  2. 9.1.1 Europe Vaccine Adjuvants Revenue by Type (2021-2032)
  3. 9.1.2 Europe Vaccine Adjuvants Sales by Type (2021-2032)
  4. 9.1.3 Europe Vaccine Adjuvants Price by Type (2021-2032)
  5. 9.2 Europe Vaccine Adjuvants Market Size by Application
  6. 9.2.1 Europe Vaccine Adjuvants Revenue by Application (2021-2032)
  7. 9.2.2 Europe Vaccine Adjuvants Sales by Application (2021-2032)
  8. 9.2.3 Europe Vaccine Adjuvants Price by Application (2021-2032)
  9. 9.3 Europe Vaccine Adjuvants Market Size by Country
  10. 9.3.1 Europe Vaccine Adjuvants Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Vaccine Adjuvants Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Vaccine Adjuvants Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Vaccine Adjuvants Market Size by Type
  2. 10.1.1 China Vaccine Adjuvants Revenue by Type (2021-2032)
  3. 10.1.2 China Vaccine Adjuvants Sales by Type (2021-2032)
  4. 10.1.3 China Vaccine Adjuvants Price by Type (2021-2032)
  5. 10.2 China Vaccine Adjuvants Market Size by Application
  6. 10.2.1 China Vaccine Adjuvants Revenue by Application (2021-2032)
  7. 10.2.2 China Vaccine Adjuvants Sales by Application (2021-2032)
  8. 10.2.3 China Vaccine Adjuvants Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Vaccine Adjuvants Market Size by Type
  2. 11.1.1 Asia Vaccine Adjuvants Revenue by Type (2021-2032)
  3. 11.1.2 Asia Vaccine Adjuvants Sales by Type (2021-2032)
  4. 11.1.3 Asia Vaccine Adjuvants Price by Type (2021-2032)
  5. 11.2 Asia Vaccine Adjuvants Market Size by Application
  6. 11.2.1 Asia Vaccine Adjuvants Revenue by Application (2021-2032)
  7. 11.2.2 Asia Vaccine Adjuvants Sales by Application (2021-2032)
  8. 11.2.3 Asia Vaccine Adjuvants Price by Application (2021-2032)
  9. 11.3 Asia Vaccine Adjuvants Market Size by Country
  10. 11.3.1 Asia Vaccine Adjuvants Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Vaccine Adjuvants Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Vaccine Adjuvants Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Vaccine Adjuvants Market Size by Type
  2. 12.1.1 SAMEA Vaccine Adjuvants Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Vaccine Adjuvants Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Vaccine Adjuvants Price by Type (2021-2032)
  5. 12.2 SAMEA Vaccine Adjuvants Market Size by Application
  6. 12.2.1 SAMEA Vaccine Adjuvants Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Vaccine Adjuvants Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Vaccine Adjuvants Price by Application (2021-2032)
  9. 12.3 SAMEA Vaccine Adjuvants Market Size by Country
  10. 12.3.1 SAMEA Vaccine Adjuvants Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Vaccine Adjuvants Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Vaccine Adjuvants Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Vaccine Adjuvants Value Chain Analysis
  2. 13.1.1 Vaccine Adjuvants Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Vaccine Adjuvants Production Mode & Process
  6. 13.2 Vaccine Adjuvants Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Vaccine Adjuvants Distributors
  9. 13.2.3 Vaccine Adjuvants Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst